analyst
AD
NASDAQ · ADPT
Adaptive Biotechnologies Corporation
Healthcare · Biotechnology
$26.68
Up+$0.99 (+3.71%)
Updated Sep 16, 2026, 11:49 PM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.45B
- P/E ratio
- -41.23
- Dividend yield
- 0.00%
- 52-week range
- $12.00 – $27.34
- Volume
- 4.12M
- Avg. volume
- 2.26M
Price performance
ADPT price history
1M range · 20 trading sessions · Daily adjusted prices
ADPT closed at $26.68 after 20 trading sessions, up 8.63% for the selected period.
- Last close
- $26.68
- Period change
- +8.63%
- Period low
- $24.20
- Period high
- $26.68
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $24.80 | $27.34 | $24.71 | $26.68 | 4.12M |
| Sep 14, 2026 | $24.26 | $24.878 | $23.965 | $24.78 | 1.73M |
| Sep 11, 2026 | $24.23 | $24.79 | $23.93 | $24.20 | 1.24M |
| Sep 10, 2026 | $23.81 | $24.65 | $23.53 | $24.23 | 1.07M |
| Sep 9, 2026 | $24.05 | $24.6799 | $23.89 | $24.42 | 1.11M |
| Sep 8, 2026 | $23.98 | $24.60 | $23.62 | $24.34 | 1.36M |
| Sep 4, 2026 | $24.06 | $24.40 | $23.94 | $24.28 | 1.4M |
| Sep 3, 2026 | $25.18 | $25.36 | $23.84 | $24.57 | 2.16M |
| Sep 2, 2026 | $24.40 | $25.23 | $24.185 | $24.66 | 1.62M |
| Sep 1, 2026 | $24.91 | $25.11 | $24.20 | $24.34 | 1.62M |
| Aug 31, 2026 | $24.61 | $25.02 | $23.865 | $24.92 | 2.24M |
| Aug 28, 2026 | $26.54 | $26.58 | $25.13 | $25.19 | 1.51M |
| Aug 27, 2026 | $26.23 | $26.87 | $26.11 | $26.44 | 1.94M |
| Aug 26, 2026 | $26.00 | $26.51 | $25.82 | $26.16 | 1.39M |
| Aug 25, 2026 | $25.805 | $26.49 | $25.2278 | $26.25 | 1.22M |
| Aug 24, 2026 | $25.80 | $25.99 | $25.09 | $25.55 | 1.69M |
| Aug 21, 2026 | $25.37 | $26.03 | $24.9301 | $25.99 | 1.82M |
| Aug 20, 2026 | $24.78 | $26.09 | $24.78 | $25.44 | 1.97M |
| Aug 19, 2026 | $25.38 | $26.16 | $25.16 | $25.49 | 2.15M |
| Aug 18, 2026 | $24.24 | $25.15 | $23.92 | $24.56 | 1.88M |
Latest ADPT news
The latest Smart Investors Daily articles mentioning ADPT.
Stock researchResearch & News · SEC Filings
Loading stock research…